Net profit of Vivanza Biosciences rose 2700.00% to Rs 0.56 crore in the quarter ended September 2025 as against Rs 0.02 crore during the previous quarter ended September 2024. Sales rose 1745.33% to Rs 55.36 crore in the quarter ended September 2025 as against Rs 3.00 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales55.363.00 1745 OPM %1.083.67 - PBDT0.570.02 2750 PBT0.560.02 2700 NP0.560.02 2700 Powered by Capital Market - Live News

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live News

Vivanza Biosciences announced that the Annual General Meeting(AGM) of the company will be held on 25 September 2025.Powered by Capital Market - Live News

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 1 September 2025.Powered by Capital Market - Live News

Net profit of Vivanza Biosciences declined 66.67% to Rs 0.09 crore in the quarter ended June 2025 as against Rs 0.27 crore during the previous quarter ended June 2024. Sales rose 266.39% to Rs 8.94 crore in the quarter ended June 2025 as against Rs 2.44 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales8.942.44 266 OPM %1.6814.75 - PBDT0.090.27 -67 PBT0.090.27 -67 NP0.090.27 -67 Powered by Capital Market - Live News